Medtronic (MDT) Tops Q4 EPS by 3c, Offers FY19 Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Medtronic, Inc. (MDT) PT Raised to $95 at RBC Capital
May 25, 2018 6:39 AM EDTRBC Capital raised its price target on Medtronic, Inc. (NYSE: MDT) to $95.00 (from $92.00) while maintaining a Outperform rating.
Analyst Glenn Novarro commented, "All four segments participated in delivering a strong F4Q18, ahead of consensus and our estimate. The upper half of... More
Medtronic, Inc. (MDT) PT Raised to $97 at Needham & Company
May 24, 2018 5:12 PM EDTNeedham & Company raised its price target on Medtronic, Inc. (NYSE: MDT) to $97.00 (from $95.00) while maintaining a Buy rating.
Analyst Mike Matson commented, "F4Q18 revenue and EPS beat consensus. Management provided initial FY19 organic revenue guidance that was slightly below consensus and EPS guidance... More
Medtronic, Inc. (MDT) PT Raised to $87 at Stifel
May 24, 2018 2:13 PM EDTStifel raised its price target on Medtronic, Inc. (NYSE: MDT) to $87.00 (from $85.00) while maintaining a Hold rating.
... MoreMedtronic, Inc. (MDT) PT Raised to $94 at Evercore ISI
May 24, 2018 1:49 PM EDTEvercore ISI raised its price target on Medtronic, Inc. (NYSE: MDT) to $94.00 (from $90.00) while maintaining an Outperform rating following results.
What analyst Vijay Kumar liked:
Strong organic top-line sales growth of 6% driven by across the board business units and geographies strength, beating ST... More